Rashid K. Sayyid
@rksayyid
MD, MSc | @USC_Urology 🤖 Onc Fellow | Previously: @MCG_Urology @UofTUrology @SUO_YUO Fellow @ihpmeuoft & @AUB_Lebanon 🇱🇧
ID: 837788693251387392
https://www.ncbi.nlm.nih.gov/pubmed/?term=rashid+sayyid 03-03-2017 22:16:04
3,3K Tweet
865 Takipçi
480 Takip Edilen
TiP SOGUG-NEOWIN: Ph 2 trial of neoadjuvant erdafitinib +/- cetrelimab in FGFR2/3 mut+ mUC (n=90) 🔹Co-primary endpoints: pCR and <ypT2 🔹Key secondary endpoints: EFS, OS, ORR, safety, surgery delays UroToday.com #ESMO24
